Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.33 |
| ▸ | LCAT | P04180 | 2/20 | 0.32 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.32 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.30 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.30 |
| ▸ | MERTK | Q12866 | 1/20 | 0.30 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24676716 | 0.76 | RAB9A (0.39) | — | |
| SCHEMBL25164697 | 0.74 | TRPV1 (0.41) | IDH1TRPV1LCATFABP4FABP5 | |
| SCHEMBL24676720 | 0.73 | — | — | |
| SCHEMBL20270106 | 0.72 | TRPV1 (0.39) | IDH1TRPV1LCATFABP4FABP5 | |
| SCHEMBL21314668 | 0.72 | TRPV1 (0.39) | IDH1TRPV1LCATFABP4FABP5 | |
| SCHEMBL29754886 | 0.72 | TRPV1 (0.43) | IDH1TRPV1LCATFABP4FABP5 | |
| SCHEMBL29754880 | 0.72 | TRPV1 (0.43) | IDH1TRPV1LCATFABP4FABP5 | |
| SCHEMBL25006020 | 0.69 | LMNA (0.35) | IDH1TRPV1FLT3TYRO3MERTK | |
| SCHEMBL25005428 | 0.69 | IDH1 (0.33) | IDH1TRPV1 | |
| SCHEMBL24677043 | 0.67 | TRPV1 (0.35) | IDH1TRPV1FABP4FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022155941-A1 | CDK2 INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2022-07-28 | — | — | WO | disclosed |